757885

544449

ANTHEM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Anthem Biosciences Ltd Share Price Today

ANTHEM BIOSCIENCES LTD is currently trading at ₹773.45, down by ₹15.25 from the previous close. During the latest trading session, the stock touched an intraday high of ₹798.00 and a low of ₹765.35. Over the past six months, ANTHEM BIOSCIENCES LTD has delivered a return of 7.98%, while the stock has declined 1.29% in the last one month.

Anthem Biosciences Ltd performance

Today’s low Today’s high
₹ 765.35 ₹ 798.00
₹ 773.20
52 week low 52 week high
₹ 579.15 ₹ 873.50
₹ 773.20
Open Price ₹ 798.00
Prev. Close ₹ 788.70
Volume (Shares) 390404.00
Total traded value ₹ 3018.60
Upper Circuit ₹ 946.40
Lower Circuit ₹ 631.00
info

Investment Returns

Over 1 Month -1.29% Over 3 Months 23.05% Over 6 Months 12.76% Over 1 Year 7.98%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Anthem Biosciences Ltd fundamentals


  • Market cap (Cr) 43,642.00
  • P/E Ratio (TTM) 66.21
  • Beta 0.73
  • Book Value / share 56.55
  • Return on equity 22.98%
  • EPS (TTM) 12.22
  • Dividend yield 0.25%
  • Net profit/quarter (Cr) 211.67
info icon alternate text
  • Market cap (Cr) 43,484.30
  • P/E Ratio (TTM) 66.21
  • Beta 0.72
  • Book Value / share 56.55
  • Return on equity 22.98%
  • EPS (TTM) 12.22
  • Dividend yield 0.25%
  • Net profit/quarter (Cr) 211.67
info icon alternate text

Anthem Biosciences Ltd Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 582.50
Operating Expense 343.37
Net Profit 211.67
Net Profit Margin (%) 36.33
Earnings Per Share (EPS) 3.77
EBITDA 328.58
Effective Tax Rate (%) 29.61
Particulars DEC 2025 (Values in Cr)
Revenue 416.58
Operating Expense 281.40
Net Profit 112.12
Net Profit Margin (%) 26.91
Earnings Per Share (EPS) 2.00
EBITDA 177.99
Effective Tax Rate (%) 25.30
Particulars SEP 2025 (Values in Cr)
Revenue 552.23
Operating Expense 352.72
Net Profit 198.43
Net Profit Margin (%) 35.93
Earnings Per Share (EPS) 3.54
EBITDA 279.45
Effective Tax Rate (%) 21.66
Particulars JUN 2025 (Values in Cr)
Revenue 538.01
Operating Expense 366.80
Net Profit 148.34
Net Profit Margin (%) 27.57
Earnings Per Share (EPS) 2.65
EBITDA 223.16
Effective Tax Rate (%) 25.43
Particulars MAR 2025 (Values in Cr)
Revenue 478.98
Operating Expense 303.96
Net Profit 122.56
Net Profit Margin (%) 25.58
Earnings Per Share (EPS) 2.19
EBITDA 235.93
Effective Tax Rate (%) 42.41
Particulars MAR 2026 (Values in Cr)
Revenue 2089.31
Operating Expense 1344.31
Net Profit 670.56
Net Profit Margin (%) 32.09
Earnings Per Share (EPS) 11.95
EBITDA 1009.19
Effective Tax Rate (%) 25.74
Particulars MAR 2025 (Values in Cr)
Revenue 1840.65
Operating Expense 1238.66
Net Profit 506.19
Net Profit Margin (%) 27.50
Earnings Per Share (EPS) 9.05
EBITDA 798.45
Effective Tax Rate (%) 28.84
Particulars MAR 2024 (Values in Cr)
Revenue 1417.54
Operating Expense 1003.28
Net Profit 374.78
Net Profit Margin (%) 26.43
Earnings Per Share (EPS) 6.61
EBITDA 575.40
Effective Tax Rate (%) 22.68
Particulars MAR 2025 (Values in Cr)
Book Value / Share 43.10
ROE % 20.82
ROCE % 28.24
Total Debt to Total Equity 0.08
EBITDA Margin 41.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 34.43
ROE % 20.04
ROCE % 23.98
Total Debt to Total Equity 0.10
EBITDA Margin 40.07
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.51
ROE % 22.25
ROCE % 27.36
Total Debt to Total Equity 0.05
EBITDA Margin 48.81
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1543.93
ROE % 39.44
ROCE % 49.35
Total Debt to Total Equity 0.07
EBITDA Margin 49.87
Particulars MAR 2021 (Values in Cr)
Book Value / Share 826.75
ROE % 48.30
ROCE % 53.40
Total Debt to Total Equity 0.23
EBITDA Margin 40.33
Particulars MAR 2025 (Values in Cr)
Book Value / Share 44.24
ROE % 22.98
ROCE % 30.46
Total Debt to Total Equity 0.06
EBITDA Margin 43.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 34.58
ROE % 20.40
ROCE % 24.74
Total Debt to Total Equity 0.08
EBITDA Margin 40.60
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.53
ROE % 22.27
ROCE % 27.47
Total Debt to Total Equity 0.05
EBITDA Margin 48.86
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1544.46
ROE % 39.48
ROCE % 49.38
Total Debt to Total Equity 0.07
EBITDA Margin 49.90
Particulars MAR 2021 (Values in Cr)
Book Value / Share 826.76
ROE % 48.30
ROCE % 53.40
Total Debt to Total Equity 0.23
EBITDA Margin 40.33
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 316.98
Total Assets 2807.58
Total Liabilities 2807.58
Total Equity 2409.86
Share Outstanding 55
Price to Book Ratio 0.00
Return on Assets (%) 16.07
Return on Capital (%) 17.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 184.35
Total Assets 2398.11
Total Liabilities 2398.11
Total Equity 1924.65
Share Outstanding 55
Price to Book Ratio 0.00
Return on Assets (%) 15.31
Return on Capital (%) 17.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 342.84
Total Assets 2014.45
Total Liabilities 2014.45
Total Equity 1740.66
Share Outstanding 57
Price to Book Ratio 0.00
Return on Assets (%) 19.12
Return on Capital (%) 20.65
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 348.90
Total Assets 1618.86
Total Liabilities 1618.86
Total Equity 1354.99
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.05
Return on Capital (%) 29.17
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.76
Total Assets 1033.82
Total Liabilities 1033.82
Total Equity 701.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 26.24
Return on Capital (%) 33.85
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 310.95
Total Assets 2835.56
Total Liabilities 2835.56
Total Equity 2473.21
Share Outstanding 55
Price to Book Ratio 0.00
Return on Assets (%) 17.85
Return on Capital (%) 19.6
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 183.84
Total Assets 2324.22
Total Liabilities 2324.22
Total Equity 1933.07
Share Outstanding 55
Price to Book Ratio 0.00
Return on Assets (%) 16.12
Return on Capital (%) 17.85
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 342.79
Total Assets 1993.01
Total Liabilities 1993.01
Total Equity 1741.61
Share Outstanding 57
Price to Book Ratio 0.00
Return on Assets (%) 19.35
Return on Capital (%) 20.78
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 348.86
Total Assets 1619.17
Total Liabilities 1619.17
Total Equity 1355.46
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 25.07
Return on Capital (%) 29.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 40.62
Total Assets 1033.73
Total Liabilities 1033.73
Total Equity 701.47
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 26.24
Return on Capital (%) 33.85
Particulars MAR 2025 (Values in Cr)
Net Income 656.86
Cash from Operations 577.33
Cash from Investing -152.11
Cash from Financing -133.60
Net change in Cash 132.62
Free Cash Flow 891.86
Particulars MAR 2024 (Values in Cr)
Net Income 477.31
Cash from Operations 260.15
Cash from Investing -221.45
Cash from Financing -77.18
Net change in Cash -158.48
Free Cash Flow 369.57
Particulars MAR 2023 (Values in Cr)
Net Income 497.29
Cash from Operations 420.98
Cash from Investing -376.01
Cash from Financing 63.97
Net change in Cash -6.05
Free Cash Flow 599.66
Particulars MAR 2022 (Values in Cr)
Net Income 546.14
Cash from Operations 455.91
Cash from Investing -205.45
Cash from Financing 180.67
Net change in Cash 308.13
Free Cash Flow 478.29
Particulars MAR 2021 (Values in Cr)
Net Income 365.56
Cash from Operations 348.28
Cash from Investing -196.03
Cash from Financing -63.26
Net change in Cash 18.33
Free Cash Flow 464.10
Particulars MAR 2025 (Values in Cr)
Net Income 711.42
Cash from Operations 598.83
Cash from Investing -246.31
Cash from Financing -66.42
Net change in Cash 127.10
Free Cash Flow 823.41
Particulars MAR 2024 (Values in Cr)
Net Income 484.77
Cash from Operations 284.40
Cash from Investing -191.75
Cash from Financing -131.59
Net change in Cash -158.94
Free Cash Flow 388.25
Particulars MAR 2023 (Values in Cr)
Net Income 497.78
Cash from Operations 433.98
Cash from Investing -377.90
Cash from Financing 52.85
Net change in Cash -6.07
Free Cash Flow 612.66
Particulars MAR 2022 (Values in Cr)
Net Income 546.59
Cash from Operations 456.34
Cash from Investing -205.77
Cash from Financing 180.67
Net change in Cash 308.24
Free Cash Flow 478.73
Particulars MAR 2021 (Values in Cr)
Net Income 365.57
Cash from Operations 348.19
Cash from Investing -196.08
Cash from Financing -63.26
Net change in Cash 18.19
Free Cash Flow 464.01
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 13.39 1.56 248.29 23.12 38.85
BLISS GVS PHARMA LTD 438.10 35.56 3.89 4646.32 118.35 462.70
CIPLA LTD. 1388.80 29.47 3.25 112193.56 1165.55 1672.20
FERMENTA BIOTECH LTD. 338.80 14.94 2.45 997.12 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 32.40 22.66 4.17 248.29 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 557.75 25.00 4.35 1612.49 490.00 789.95
ASTRAZENECA PHARMA IND LT 8243.90 107.66 23.61 20609.75 7630.00 10653.05
BLISS GVS PHARMA LTD 438.10 47.26 4.02 4646.32 118.35 462.70

Anthem Biosciences Ltd shareholding pattern

Holding
12.49%
74.67%
1.28%
11.54%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Anthem Biosciences Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
774.90 -1.74 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 776.90
  • 26 Days 766.10
  • 10 Days 771.90
  • 50 Days 749.70
  • 12 Days 771.20
  • 100 Days 728.70
  • 20 Days 768.90
  • 200 Days 723.70
787.32 PIVOT
First Support 779.63 First Resistance 796.38 Second Support 770.57 Second Resistance 804.07 Third Support 762.88 Third Resistance 813.13
RSI 59.42 ADX 9.82 MACD 5.05 Williams % R -10.71 Commodity Channel Index (CCI) 93.44
Date 2026-06-12 Week 192327.00 Same Day 261989.00 Month 291766.00
1 Year 0.74 3 Year 0.74
Over 1 Month
-1.29% down
Over 1 Year
7.98% down
Over 3 Months
23.05% down
Over 3 Years
0.00% down
Over 6 Months
12.76% down
Over 5 Years
0.00% down

Anthem Biosciences Ltd Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
25 Jun 2026 2.0 Final 26 Jun 2026 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
25 Jun 2026 2.0 Final 26 Jun 2026 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Anthem Biosciences Ltd?

Answer Field

Anthem Biosciences Ltd share price is for NSE ₹ 773.45 & for BSE ₹ 770.00 as on Jun 15 2026 03:30 PM.

What is the Market Cap of Anthem Biosciences Ltd Share?

Answer Field

The market cap of Anthem Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 15 2026 03:30 PM.

What is the 52 Week High and Low of Anthem Biosciences Ltd?

Answer Field

The 52 Week High and Low of Anthem Biosciences Ltd for NSE is ₹ 873.50 and ₹ 579.15 and for BSE is ₹ 873.25 and ₹ 579.45.

What is 1 year return for Anthem Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been 7.98%.

What is the P/E Ratio of Anthem Biosciences Ltd Share?

Answer Field

As on Jun 15 2026 03:30 PM the price-to-earnings (PE) ratio for Anthem Biosciences Ltd share is 66.21.

What is the PB ratio of Anthem Biosciences Ltd Share?

Answer Field

As on Jun 15 2026 03:30 PM, the price-to-book (PB) ratio for Anthem Biosciences Ltd share is 56.55.

How to Buy Anthem Biosciences Ltd Share?

Answer Field

You can trade in Anthem Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Anthem Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Anthem Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Anthem Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|